NCT03489473 FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment Status UNKNOWN Phase N/A
NCT03476798 Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium Status COMPLETED Phase PHASE2
NCT03466788 Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer Status COMPLETED Phase NA
NCT03466034 The Role of Hypoxia as a Selective Pressure for TP53 Mutations Status TERMINATED Phase N/A
NCT03463252 Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC Status RECRUITING Phase PHASE2/PHASE3
NCT03454451 CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers Status COMPLETED Phase PHASE1
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Status RECRUITING Phase N/A
NCT03395080 A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma Status COMPLETED Phase PHASE2
NCT03394027 ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma Status COMPLETED Phase PHASE2
NCT03366480 A Study to Assess the Efficacy and Safety of ABTL0812 Status COMPLETED Phase PHASE1/PHASE2
NCT03349463 Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. Status UNKNOWN Phase PHASE4
NCT03345485 Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. Status COMPLETED Phase PHASE1/PHASE2
NCT03339843 Multiorgan Metabolic Imaging Response Assessment of Abemaciclib Status COMPLETED Phase PHASE2
NCT03330015 Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding Status COMPLETED Phase N/A
NCT03324958 VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. Status TERMINATED Phase NA
NCT03322176 Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing Status UNKNOWN Phase N/A
NCT03314935 A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors Status COMPLETED Phase PHASE1/PHASE2